相关实验视频

Updated: May 5, 2026

Three-dimensional Biomimetic Technology: Novel Biorubber Creates Defined Micro- and Macro-scale Architectures in Collagen Hydrogels

Three-dimensional Biomimetic Technology: Novel Biorubber Creates Defined Micro- and Macro-scale Architectures in Collagen Hydrogels

Published on: February 12, 2016

河巴西颗粒的流体接口揭示了大小对早期凝固步骤的影响

Marion Baudoin¹, Gilles Paboeuf², Siriluck Liengprayoon³

¹IPR - UMR UR1 CNRS 6251, Rennes University, Rennes F-35000, France; CIRAD, UPR BioWooEB, Montpellier F-34398, France; BioWooEB, Univ Montpellier, CIRAD, Montpellier, France.

Colloids and surfaces. B, Biointerfaces

|October 3, 2024

概括

来自Hevea brasiliensis乳的小型和大型颗粒 (RP) 在空气-液体界面表现出不同的吸附行为. 小颗粒 (SRP) 形成稳定的薄膜比大颗粒 (LRP) 快,影响凝固动态.

科学领域:

生物物理学的生物物理.
体科学体科学体科学
材料科学材料科学材料科学

背景情况:

天然来自Hevea brasiliensis乳,含有小型颗粒 (SRP) 和大型颗粒 (LRP).
了解这些颗粒的早期凝固步骤对于加工至关重要.

研究的目的:

根据它们的尺寸,研究Hevea颗粒 (RP) 的早期凝固步骤.
了解SRP和LRP在空气液体界面的吸附行为和界面膜形成.

主要方法:

通过离心,将SRP和LRP从Hevea乳中分离出来.
粒子大小和泽塔潜力的表征.
在空气-液体界面的吸附性研究使用Langmuir槽.
通过表面张力和圆测量分析界面膜形成动力学和稳定性.
微观分析 (BAM,AFM,CLSM) 来确定颗粒的排列方式.

主要成果:

实际上,SRP和LRP在基本缓冲中是分离和稳定的.
在空气液体界面上,SRP吸附和薄膜稳定比LRP更快.
观察到SRP和LRP在接口上的不同安排:SRP融合,而LRP形成浮动聚合物.
该研究讨论了非异烯分子和特定蛋白质 (SRPP1,REF1) 在这些差异中的作用.

结论:

颗粒大小显著影响了Hevea颗粒的吸附动力学和界面膜组织.
SRP和LRP的独特行为表明,在天然凝固的早期阶段,它们的作用取决于大小.

关键词:

原子力显微镜 (AFM) 的使用同焦点激光扫描显微镜 (CLSM) 的使用圆测量方法圆测量方法希维亚巴西兰西斯 (Hevea brasiliensis) 乳是一种乳.接口行为接口行为朗格穆尔电影兰格穆尔电影大型颗粒 (LRP) 是一种颗粒大小分布颗粒大小分布小型颗粒 (SRP) 是一种小的颗粒.

更多相关视频

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices

An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices

Published on: August 21, 2020

相关概念视频

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...